PF-446687

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NamePF-446687
Drug Alias NamePF-446687
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanocortin receptor 3 agonists
TargetsMelanocortin receptor 3
Therapy Area/IndicationsErectile DysfunctionSexual Dysfunction, Physiological
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenNorwayDenmark +[4] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsErectile DysfunctionSexual Dysfunction, Physiological

Other Information

ATC CodeN/A
Related LinksN/A